azilsartan

Azilsartan (TAK-536) 是一种高活性的血管紧张素Ⅱ1型受体特异性拮抗剂(IC50:2.6 nM)。

Azilsartan is an angiotensin II receptor antagonist for the treatment of hypertension and was developed by Takeda. Azilsartan Medoxomil lowers blood pressure by blocking the effects of angiotensin II, a type of vasopressin.

Azilsartan mepixetil is a potent angiotensin II receptor antagonist with enhanced efficacy and prolonged duration of action. It exhibits more prominent and sustained effects in lowering blood pressure and heart rate, while maintaining a high level of safety. Furthermore, Azilsartan mepixetil demonstrates optimal protective efficacy for cardiovascular and renal functions. Hence, it holds promise for the research and treatment of hypertension, chronic heart failure, and diabetic nephropathy.

Azilsartan mopivabil 是血管紧张素 II 受体 (angiotensin II receptor) 的强效拮抗剂。

Azilsartan mepixetil potassium (QR-01019K)，是一种高效安全的血管紧张素 II 受体拮抗剂，展现出卓越的持久降压效应以及显著且持续的降心率功能，有望用于治疗高血压、慢性心力衰竭和糖尿病肾病。

Azilsartan Medoxomil Potassium (TAK-491 Potassium) 是一种具有口服活性的1型血管紧张素 II 受体拮抗剂(IC50: 0.62 nM)。

Azilsartan Methyl Ester 是血管紧张素 II 受体拮抗剂，抑制[125I]AII（0.2nM）与牛肾上腺皮质的特异性结合，IC50值为0.44uM。

Azilsartan (TAK-536) D5 is the deuterium-labeled Azilsartan. Azilsartan is a specific antagonist of the angiotensin II type 1 receptor.

Azilsartan Medoxomil (TAK-491) 是一种具有口服活性的1型血管紧张素II 受体拮抗剂(IC50:0.62 nM)。